Fractyl Health, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.9765 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 12.95M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Details
| Name | Fractyl Health, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 100 |
| Founded | 2010 |
| Ipo Date | 2024-02-02 |
| Ceo | Harith Rajagopalan |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 15.00 |
| Isin | US35168W2026 |
| Cusip | 35168W202 |
| Cik | 1572616 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Jay D. Caplan BSEE, MBA | Co-Founder, Chief Product Officer and President |
| Sarah S. Toomey Esq. | General Counsel and Corporate Secretary |
| Lara Smith Weber | Chief Financial Officer and Treasurer |
| Brian Luque | Head of Investor Relations and Corporate Development |
| Jon Fitzgerald | Senior Vice President of Regulatory, Quality and Clinical |
| Mike Zumdahl | Senior Vice President of Market Access and Commercial Strategy |
Contact
| Address | 3 Van de Graaff Drive, Suite 200, Burlington, Massachusetts 01803, United States |
| Phone | 781 902 8800 |
| Website | https://fractyl.com |